Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New treatments for multiple sclerosis: at what long-term risk?
Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report.
Cohort Study Comparing the Berg Balance Scale and the Mini-BESTest in Ambulatory People With Multiple Sclerosis.
Restless Legs Syndrome in Multiple Sclerosis.
Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
Immunotherapy of Neuromyelitis Optica.
Cortical excitability changes over time in progressive multiple sclerosis.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases.
Progressive multifocal leukoencephalopathy: cavitary white matter lesions.
Patients' perspectives on quality of mental health care for people with MS.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Optic neuritis: A blurry issue.
[Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis.]
Slowed Exercise-Onset Vo2 Kinetics During Submaximal Endurance Exercise in Subjects With Multiple Sclerosis.
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Gait disorders in multiple sclerosis.
Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
[Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases.]
Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.

Pages